Skip to main content
. 2018 Jan 11;4:1. doi: 10.1038/s41523-017-0053-3

Fig. 2.

Fig. 2

Kaplan–Meier estimates of progression-free and overall survival in the ENCORE301 trial. Adapted with permission from Yardley et al. JCO 2013